Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05363020 · ClinicalTrials.gov registry record · Phase 4
S-Asenosyl-L-Methionine vs Placebo for Osteoarthritis of the Hands
A Phase 4 study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT05363020 is a Phase 4 study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 40 participants.
The verdict
NCT05363020, a Phase 4 study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
The primary objective of this study is to demonstrate the feasibility of evaluating SAMe tolerability, analgesic benefits, and daily functional improvement in patients with osteoarthritis of the hands compared to placebo. The secondary objective of this study is to generate preliminary data on discomfort, function, quality of life in patients with osteoarthritis of the hands when taking SAMe compared to placebo.
Interventions
- DRUG Placebo
- DRUG S-Adenosyl-L-Methionine (Sam-E)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-08-17 |
| Est. Completion | 2025-04-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05363020
The ClinicalTrials.gov registry entry for NCT05363020 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05363020 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05363020 about?
NCT05363020 is a clinical study titled "S-Asenosyl-L-Methionine vs Placebo for Osteoarthritis of the Hands". The primary objective of this study is to demonstrate the feasibility of evaluating SAMe tolerability, analgesic benefits, and daily functional improvement in patients with osteoarthritis of the hands compared to placebo. The secondary objective of this study is to generate preliminary data on disco...
What is the current status of trial NCT05363020?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2022-08-17. Estimated completion is 2025-04-11.
What interventions are being tested in trial NCT05363020?
The interventions under investigation include: Placebo (DRUG), S-Adenosyl-L-Methionine (Sam-E) (DRUG).
Who is sponsoring clinical trial NCT05363020?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.